HMG-CoA reductase inhibitor therapy and the risk of venous thromboembolism in joint replacement surgery
March 1, 2010|Cleveland Clinic Journal of Medicine
Author and Disclosure Information
William Ho, MBBS
St. Vincent’s Hospital, Melbourne, Victoria, Australia
Brendan Flaim, MBBS, FRACP
St. Vincent’s Hospital, Melbourne, Victoria, Australia
Andrea Chan, MBBS, FRACP
St. Vincent’s Hospital, Melbourne, Victoria, Australia